Allergies pose a significant challenge to patients worldwide. How can we use novel immunotherapy approaches to lessen their therapeutic burden?

Can drugs change membrane protein function by altering the lipid bilayer environment? That’s what this researcher wanted to find out

SynaptixBio’s CEO discusses the personal road that led him to the fight against the rare disease H-ABC.

How can we support women's careers in pharmaceutical sciences?

We catch up with Christine Callahan from Thermo Fisher Scientific about how suppliers and customers need to reimagine their business models.

We spoke to Prateek Gadhoke, Global Head of Specialty Care Procurement at Sanofi, to ask what makes a strong supply chain.

An interview with Ken Gruber of Endevica Bio on his work producing a treatment for cachexia, a wasting condition common in late-stage cancer.

Watch our video interview with We interview Joe Healey, CEO and Co-Founder of NanoSyrinx.

We interview Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company.